Superworth

Bluejay Diagnostics market cap BJDX

Share price times shares outstanding: what the whole company sells for, since 2021.

Today, Nov 2, 2026
$592K
Highest close in our data
$15.2M
Dec 2021

Bluejay Diagnostics is worth $592K at the close on Nov 2, 2026, at $0.53 a share.

That is up 1% over the last year and down 96% over five years.

Its highest close in our data was $15.2M in Dec 2021.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$592K$210.9K$1.3M+86%
2025$317.5K$231.3K$1.2M−35%
2024$486.6K$32.6K$622.4K+29%
2023$377.9K$377.9K$4.1M−80%
2022$1.9M$1.9M$13M−85%
2021$12.5M$12.5M$15.2Mn/a

Against its peers

Companies in Medical - Instruments & Supplies nearest Bluejay Diagnostics' size, closest first, today.

CompanyMarket cap
BJDXBluejay Diagnostics$592K
VJETFlyte Aviation$846.1K
PFSAProfusa$394.3K
IVFINVO Fertility$1.1M
BBLGBone Biologics$1.3M
TNONTenon Medical$1.3M
AMIXAutonomix Medical$1.6M
NXGLNexgel$1.8M
ADGMAdagio Medical$1.9M
GCTKGlucotrack$172.8K
XAIRBeyond Air$2.1M
Peer median$1.3M

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Bluejay Diagnostics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.